Since 2012, there has been a steep increase in the number of reported congenital syphilis cases in the United States, and there are ongoing concerns about chlamydia, gonorrhea and syphilis infections among people taking pre-exposure prophylaxis (PrEP) treatment. Medicaid programs nationally are significant payers for health care related to sexually transmitted infections (STIs). Monitoring adherence to screening recommendations for STIs is critical to ensuring Medicaid members are receiving appropriate care, reducing the risk of adverse maternal and infant health outcomes, and reducing the progression of STIs.

 

The Georgia Health Policy Center is working with the Centers for Disease Control and Prevention, AcademyHealth, and representatives from Health and Human Services Region 4 states (Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee) to analyze recent Medicaid data to assess the number of syphilis tests that are performed among pregnant Medicaid beneficiaries as well as rates of chlamydia, gonorrhea and syphilis testing among Medicaid beneficiaries who are taking PrEP.

Health & Healthcare Financing

Policy & Economic Analysis